SEOUL, July 26 (Korea Bizwire) — The South Korean government on Sunday decided to push to revise the law to require foreign coronavirus patients to cover the costs of their treatment amid a spike in the number of new infections among foreigners arriving from abroad. The decision was reached at a pan-governmental COVID-19 meeting of [...]
SEOUL, July 20 (Korea Bizwire) — Celltrion, a leading pharmaceutical firm in South Korea, said Monday that it is preparing to start commercial production of its antibody treatment for the new coronavirus as early as September. Celltrion plans to begin the production of its antiviral antibody treatment for the COVID-19 virus at its plant in [...]
SEOUL, June 17 (Korea Bizwire) — South Korea will test treatment and vaccine candidates against the new coronavirus on monkeys this month, the science ministry said Wednesday. Two experimental treatments and one vaccine candidate against the novel coronavirus under development by unidentified firms or research organizations will be tested on monkeys as part of the [...]
SEOUL, June 11 (Korea Bizwire) — South Korean biopharmaceutical maker Genexine Inc. said Thursday it has won approval to conduct a clinical trial for its potential coronavirus treatment in the United States. The U.S. Food and Drug Administration (FDA) gave the green light for the phase 1 clinical trial of anti-cancer drug candidate GX-I7 for [...]
SEOUL, June 3 (Korea Bizwire) — A Korean scientist has succeeded in curing Parkinson’s disease using a patient’s own stem cells for the first time in history. Prof. Kim Kwang-soo of McLean Hospital, Harvard Medical School and his research team announced Tuesday that they had succeeded in a clinical treatment of transplanting stem cells extracted [...]
SEOUL, June 1 (Korea Bizwire) — South Korean biopharmaceutical firm Celltrion Inc. announced Monday that positive results were shown for its treatment for the novel coronavirus in animal testing. The company said its antiviral antibody treatment showed a 100-fold reduction in the viral load of SARS-CoV-2, the virus known to be causing COVID-19, in an [...]
SEOUL, May 27 (Korea Bizwire) — South Korean pharmaceutical companies have joined the global race to develop a vaccine for the novel coronavirus, but none of them have received approval for clinical trials for a vaccine or treatment candidates from the country’s drug safety agency. Celltrion Inc., a major pharmaceutical giant, has announced that it [...]
SEOUL, April 24 (Korea Bizwire) — South Korea said Friday it will shorten an approval process later this month for clinical trials and research for experimental vaccines and treatment to combat the novel coronavirus. Under the move, an approval process will be shortened to less than a week from the current one or two months, [...]
NIJMEGEN, the Netherlands, April 15 (Korea Bizwire) – Khondrion, a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial disease, has published a scientific hypothesis that the inflammatory lipid modulator, prostaglandin E2 (PGE2), may execute a prominent role in COVID-19 pathophysiology and proposes that its lead drug candidate, sonlicromanol, currently in phase IIb development to [...]
SEOUL, April 10 (Korea Bizwire) — President Moon Jae-in and Microsoft co-founder Bill Gates agreed Friday to expand cooperation in efforts to develop vaccines and treatments against the new coronavirus during their phone talks, Cheong Wa Dae said. In their 25-minute conversation, made at Gates’ request, they focused on ways to tackle COVID-19 sweeping through [...]